NCT02057341 - A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

LMNA-Related Dilated Cardiomyopathy

Interventions

DRUG

ARRY-371797, p38 inhibitor; oral

multiple dose, single schedule

Trial Locations (6)

Johns Hopkins University, Baltimore

The Ohio State University, Columbus

Meriter Wisconsin Heart, Madison

University of Colorado School of Medicine, Aurora

Stanford University School of Medicine, Stanford

Brigham and Women's Hospital, Boston